blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1315502

EP1315502 - METHOD FOR TREATING ERECTILE DYSFUNCTION AND INCREASING LIBIDO IN MEN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.01.2011
Database last updated on 02.07.2024
Most recent event   Tooltip21.01.2011No opposition filed within time limitpublished on 23.02.2011  [2011/08]
Applicant(s)For all designated states
Unimed Pharmaceuticals, LLC
901 Sawyer Road
Marietta, GA 30062 / US
For all designated states
LABORATOIRES BESINS INTERNATIONAL
3, rue du Bourg l'Abbé
75003 Paris / FR
[N/P]
Former [2009/48]For all designated states
Unimed Pharmaceuticals, LLC
901 Sawyer Road
Marietta GA 30062 / US
For all designated states
LABORATOIRES BESINS INTERNATIONAL
3, rue du Bourg l'Abbé
75003 Paris / FR
Former [2008/36]For all designated states
UNIMED PHARMACEUTICALS, INC.
901 Sawyer Road
Marietta, Georgia 30062 / US
For all designated states
LABORATOIRES BESINS INTERNATIONAL
3, rue du Bourg l'Abbé
75003 Paris / FR
Former [2008/27]For all designated states
UNIMED PHARMACEUTICALS, INC.
901 Sawyer Road
Marietta, Georgia 30062 / US
For all designated states
LABORATOIRES BESINS INTERNATIONAL
5, rue du Bourg l'Abbé
75003 Paris / FR
Former [2003/23]For all designated states
Unimed Pharmaceuticals Inc.
Four Parkway North
Deerfield, IL 60015 / US
Inventor(s)01 / DUDLEY, Robert, E.
636 Wayland Avenue
Kenilworth, IL 60043 / US
 [2003/23]
Representative(s)Nargolwalla, Cyra, et al
Cabinet Plasseraud
ATTENTION : ADDRESS INACTIVE - USE ASS-NR - CDR
Paris / FR
[N/P]
Former [2005/44]Nargolwalla, Cyra, et al
Cabinet Plasseraud 65/67 rue de la Victoire
75440 Paris Cedex 09 / FR
Former [2003/23]Gosmann, Martin, Dr., et al
Solvay Pharmaceuticals GmbH, Patentabteilung, Hans-Böckler-Allee 20
30173 Hannover / DE
Application number, filing date01966486.129.08.2001
[2003/23]
WO2001US27205
Priority number, dateUS2000065177730.08.2000         Original published format: US 651777
US2000070375301.11.2000         Original published format: US 703753
[2003/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0217927
Date:07.03.2002
Language:EN
[2002/10]
Type: A1 Application with search report 
No.:EP1315502
Date:04.06.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 07.03.2002 takes the place of the publication of the European patent application.
[2003/23]
Type: B1 Patent specification 
No.:EP1315502
Date:17.03.2010
Language:EN
[2010/11]
Search report(s)International search report - published on:EP07.03.2002
ClassificationIPC:A61K31/565, A61K31/519, A61K47/10, A61K47/14, A61P5/26
[2009/38]
CPC:
A61K31/568 (EP,KR,US); A61K31/565 (EP,US); A61K31/5685 (EP,US);
A61K45/06 (EP,US); A61K47/10 (EP,US); A61K47/12 (EP,US);
A61K47/14 (EP,US); A61K47/32 (EP,US); A61K9/0014 (EP,US);
A61P15/02 (EP); A61P15/08 (EP); A61P15/10 (EP);
A61P15/12 (EP); A61P19/10 (EP); A61P21/06 (EP);
A61P25/18 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P27/12 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P3/14 (EP); A61P31/18 (EP);
A61P35/00 (EP); A61P43/00 (EP); A61P5/00 (EP);
A61P5/24 (EP); A61P5/26 (EP); A61P5/48 (EP);
A61P9/00 (EP); A61P9/10 (EP); A61P9/12 (EP) (-)
C-Set:
A61K31/565, A61K2300/00 (EP,US);
A61K31/565, A61K31/415 (EP,US);
A61K31/565, A61K31/475 (US,EP);
A61K31/565, A61K31/485 (US,EP);
A61K31/565, A61K31/52 (US,EP);
A61K31/565, A61K31/557 (US,EP);
A61K31/568, A61K2300/00 (EP,US)
(-)
Former IPC [2003/23]A61K31/565, A61K47/10, A61K47/14, A61P5/26
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/23]
Extension statesAL31.03.2003
LT31.03.2003
LV31.03.2003
MK31.03.2003
RO31.03.2003
SI31.03.2003
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON EREKTIONSSTÖRUNGEN UND STEIGERUNG DER LIBIDO BEI MÄNNERN[2003/23]
English:METHOD FOR TREATING ERECTILE DYSFUNCTION AND INCREASING LIBIDO IN MEN[2003/23]
French:METHODE POUR TRAITER LA DYSERECTION ET AUGMENTER LA LIBIDO CHEZ L'HOMME[2003/23]
Entry into regional phase31.03.2003National basic fee paid 
31.03.2003Designation fee(s) paid 
31.03.2003Examination fee paid 
Examination procedure29.03.2002Request for preliminary examination filed
International Preliminary Examining Authority: US
31.03.2003Examination requested  [2003/23]
02.04.2004Despatch of a communication from the examining division (Time limit: M06)
16.11.2004Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
07.01.2005Reply to a communication from the examining division
30.03.2006Despatch of a communication from the examining division (Time limit: M06)
12.09.2006Reply to a communication from the examining division
14.09.2009Communication of intention to grant the patent
06.01.2010Fee for grant paid
06.01.2010Fee for publishing/printing paid
Opposition(s)20.12.2010No opposition filed within time limit [2011/08]
Request for further processing for:07.01.2005Request for further processing filed
07.01.2005Full payment received (date of receipt of payment)
Request granted
25.01.2005Decision despatched
Fees paidRenewal fee
01.09.2003Renewal fee patent year 03
31.08.2004Renewal fee patent year 04
19.08.2005Renewal fee patent year 05
26.07.2006Renewal fee patent year 06
26.07.2007Renewal fee patent year 07
28.07.2008Renewal fee patent year 08
10.06.2009Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]WO9325168  (THERATECH INC [US]) [X] 1-31 * claims 1-9,17,21,24 * * page 19; example 3; table 2 * [Y] 32-56;
 [Y]WO9966870  (LAVIPHARM LAB INC [US]) [Y] 32-56 * claims 1-8,21-23 ** page 9, line 18 - line 29 *;
 [Y]WO0045795  (CIPLA LIMITED [IN], et al) [Y] 32-56 * claims 1-3,5,10,15,18 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.